• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      iLet Bionic Pancreas Cleared by FDA

      iLet Bionic Pancreas Cleared by FDA

      Urine Test for Parkinson’s Disease

      Urine Test for Parkinson’s Disease

      Investigating Bacterial Motion for New Treatment Strategies

      Investigating Bacterial Motion for New Treatment Strategies

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

    • Radiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

    • Cardiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Pencil-on-Paper Wearable Sensor

      Pencil-on-Paper Wearable Sensor

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

    • Surgery
      Device Moves Esophagus for Cardiac Ablation Procedure

      Device Moves Esophagus for Cardiac Ablation Procedure

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Temperature Feedback for Prosthetic Limbs

      Temperature Feedback for Prosthetic Limbs

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Stomach Cancer Drugs Market to Surpass US$ 6.6 Billion by 2026 and is Expected to Register a CAGR of 5.4%, Global Industry Analysis by Size, Growth, Future Trends, Key Players, Regional Data

August 26th, 2019 Coherent Market Insights Releases

Global Stomach Cancer Drugs Market, By Therapy Type (Kinase Inhibitors, Nucleoside Metabolic Inhibitors, Anthracyclines, Microtubule Inhibitors, VEGF Antibodies, HER2 Receptor Antagonists, Car T Cell Therapy), By Application (Adenocarcinomas, Gastrointestinal Stromal Tumors and Carcinoid Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$  4.0 billion in 2017, and is projected to exhibit a CAGR of 5.4% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.

Increasing Food and Drug Administration (FDA) approvals of biosimilars and developing pipeline of new drug for treatment of stomach cancer are expected to drive the stomach cancer drugs market size. For instance, in January 2019, the U.S. FDA approved South Korea’s Samsung Bioepis’ Ontruzant (trastuzumab biosimilar) for the treatment of metastatic gastric cancer or gastro-esophageal junction adenocarcinoma. Samsung Bioepis is a joint venture between Samsung Biologics and Biogen. The biosimilar was approved by the European Commission (EC) in November 2017.

Many companies such as Pfizer Inc., Merck & Co., Bristol-Meyer Squibb, and Eli Lilly & Company are focused on drugs which are in the pipeline such as Ipilimumab and Nivolumab and are expected to launch in near future. For instance, in 2018, Bristol-Meyer Squibb’s Opdivo (Nivolumab) intravenous infusion injection is in the development pipeline. It is in phase 3 for treatment of stomach cancer and is expected to launch in the U.S., Europe, and South Korea.

Emerging research, developmental studies, and clinical trials to understand stomach cancer better and to develop medicine are highly contributing to the stomach cancer drugs market revenue. One of the most recent updates of clinical trials for stomach cancer in March 2019, is the research on Helicobacter pylori eradication for gastric cancer prevention in the general population. This research is being sponsored by National Cancer Center, Korea and has entered into phase 3 showing positive results using bismuth-based quadruple therapy. Furthermore, in December 2018, Korean South West Oncology Group started a clinical trial on efficacy and safety of combination therapy with ramucirumab, paclitaxel, and trastuzumab biosimilar as a second line treatment of HER2 positive metastatic gastric cancer after failure of first line chemotherapy including trastuzumab. This study is in phase 2 and is expected to complete in 2022.

Moreover, various companies in the stomach cancer drugs market are focused on making strategic partnerships and collaborations in order to gain significant market share. For instance, in October 2016, Teva Pharmaceuticals partnered with Celltrion Healthcare Co. Ltd to commercialize biosimilar versions of Roche’s Herceptin to strengthen their product portfolio and fill a gap in its biosimilars pipeline.

Browse 38 Market Data Tables and 27 Figures spread through 178 Pages and in-depth TOC on “Stomach Cancer Drugs  Market, By Therapy Type (Kinase Inhibitors, Nucleoside Metabolic Inhibitors, Anthracyclines, Microtubule Inhibitors, VEGF Antibodies, HER2 Receptor Antagonists, Car T Cell Therapy), By Application (Adenocarcinomas, Gastrointestinal Stromal Tumors and Carcinoid Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026″

Receive a Sample of Stomach Cancer Drugs Research: https://www.coherentmarketinsights.com/insight/request-sample/2667

Key Takeaways of the Stomach Cancer Drugs Market:

  • The global stomach cancer drugs market is expected to expand at a CAGR of 5.4% during the forecast period (2018–2026), owing to increasing research & development activities, and demand for genomic and repertoire sequencing-based research.
  • Among therapy type, the Car T cells segment are expected to earn maximum growth opportunity. For instance, in 2017, pembrolizumab (Keytruda) the immunotherapy agent was approved by the U.S. Food and Drug Administration (FDA) to treat stomach cancer in some patients whose previous treatment did not work or stopped working, and it proved to be better than chemotherapy.
  • Major players operating in the global stomach cancer drugs market include Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline Plc., Kuhnil Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Merck KGaA, AstraZeneca Plc, Otsuka Holdings Co. Ltd., Sanofi S.A., and F. Hoffmann-La Roche Ltd, Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb (BMS), Jiangsu HengRui Medicine Co. Ltd., Gilead Science Inc., Celgene Corporation, Taiho Pharmaceutical, Boston Biomedical Inc., and Merck & Co.

Detailed Segmentation:

  • Global Stomach Cancer Drugs Market, By Therapy Type:
    • Kinase Inhibitors
    • Nucleoside Metabolic Inhibitors
    • Anthracyclines
    • Microtubule Inhibitors
    • VEGF Antibodies
    • HER2 Receptor Antagonists
    • Car T Cell Therapy
  • Global Stomach Cancer Drugs Market, By Application:
    • Adenocarcinomas
    • Gastrointestinal Stromal Tumors
    • Carcinoid Tumors
  • Global Stomach cancer drugs Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Stomach cancer drugs Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Eli Lilly and Company
    • GlaxoSmithKline Plc.
    • Kuhnil Pharmaceutical Co. Ltd.
    • Daiichi Sankyo Co. Ltd.
    • Merck KGaA
    • AstraZeneca Plc.
    • Otsuka Holdings Co. Ltd.
    • Sanofi S.A.
    • F. Hoffmann-La Roche Ltd.
    • Ono Pharmaceutical Co. Ltd.
    • Bristol-Myers Squibb (BMS)
    • Jiangsu HengRui Medicine Co. Ltd.
    • Gilead Science Inc.
    • Celgene Corporation
    • Taiho Pharmaceutical
    • Boston Biomedical Inc.
    • Merck & Co.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Name: Mr. Raj Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email